486 related articles for article (PubMed ID: 11917201)
21. Effect of atorvastatin therapy on oxidant-antioxidant status and atherosclerotic plaque formation.
Sezer ED; Sozmen EY; Nart D; Onat T
Vasc Health Risk Manag; 2011; 7():333-43. PubMed ID: 21731885
[TBL] [Abstract][Full Text] [Related]
22. Red grape seed extract improves lipid profiles and decreases oxidized low-density lipoprotein in patients with mild hyperlipidemia.
Razavi SM; Gholamin S; Eskandari A; Mohsenian N; Ghorbanihaghjo A; Delazar A; Rashtchizadeh N; Keshtkar-Jahromi M; Argani H
J Med Food; 2013 Mar; 16(3):255-8. PubMed ID: 23437789
[TBL] [Abstract][Full Text] [Related]
23. Comparative effects of atorvastatin, simvastatin, and fenofibrate on serum homocysteine levels in patients with primary hyperlipidemia.
Milionis HJ; Papakostas J; Kakafika A; Chasiotis G; Seferiadis K; Elisaf MS
J Clin Pharmacol; 2003 Aug; 43(8):825-30. PubMed ID: 12953339
[TBL] [Abstract][Full Text] [Related]
24. Effects of statins (atorvastatin) on serum lipoprotein levels in patients with primary hyperlipidemia and coronary heart disease.
Jurukovska-Nospal M; Arsova V; Levchanska J; Sidovska-Ivanovska B
Prilozi; 2007 Dec; 28(2):137-48. PubMed ID: 18356785
[TBL] [Abstract][Full Text] [Related]
25. Circulating oxidized low-density lipoprotein and its association with carotid intima-media thickness in asymptomatic members of familial combined hyperlipidemia families.
Liu ML; Ylitalo K; Salonen R; Salonen JT; Taskinen MR
Arterioscler Thromb Vasc Biol; 2004 Aug; 24(8):1492-7. PubMed ID: 15205217
[TBL] [Abstract][Full Text] [Related]
26. The effect of concentrated n-3 fatty acids versus gemfibrozil on plasma lipoproteins, low density lipoprotein heterogeneity and oxidizability in patients with hypertriglyceridemia.
Stalenhoef AF; de Graaf J; Wittekoek ME; Bredie SJ; Demacker PN; Kastelein JJ
Atherosclerosis; 2000 Nov; 153(1):129-38. PubMed ID: 11058707
[TBL] [Abstract][Full Text] [Related]
27. Efficacy of atorvastatin therapy in ischaemic heart disease - effects on oxidized low-density lipoprotein and adiponectin.
Miyagishima K; Hiramitsu S; Kato S; Kato Y; Kitagawa F; Teradaira R; Shinohara R; Mori K; Kimura H; Ueda T; Ohtsuki M; Morimoto S; Hishida H
J Int Med Res; 2007; 35(4):534-9. PubMed ID: 17697531
[TBL] [Abstract][Full Text] [Related]
28. Macrophage foam cell formation during early atherogenesis is determined by the balance between pro-oxidants and anti-oxidants in arterial cells and blood lipoproteins.
Aviram M
Antioxid Redox Signal; 1999; 1(4):585-94. PubMed ID: 11233155
[TBL] [Abstract][Full Text] [Related]
29. The ability of statins to protect low density lipoprotein from oxidation in hypercholesterolemic patients.
Thallinger C; Urbauer E; Lackner E; Graselli U; Kostner K; Wolzt M; Joukhadar C
Int J Clin Pharmacol Ther; 2005 Dec; 43(12):551-7. PubMed ID: 16372516
[TBL] [Abstract][Full Text] [Related]
30. Vitamin E supplementation in hyperlipidaemic patients: effect of increasing doses on in vitro and in vivo low-density lipoprotein oxidation.
Wen Y; Killalea S; Norris LA; Cooke T; Feely J
Eur J Clin Invest; 1999 Dec; 29(12):1027-34. PubMed ID: 10583450
[TBL] [Abstract][Full Text] [Related]
31. Chitotriosidase genotype and serum activity in subjects with combined hyperlipidemia: effect of the lipid-lowering agents, atorvastatin and bezafibrate.
Canudas J; Cenarro A; Civeira F; Garcí-Otín AL; Arístegui R; Díaz C; Masramon X; Sol JM; Hernández G; Pocoví M
Metabolism; 2001 Apr; 50(4):447-50. PubMed ID: 11288040
[TBL] [Abstract][Full Text] [Related]
32. Effect of ezetimibe/atorvastatin combination on oxidized low density lipoprotein cholesterol in patients with coronary artery disease or coronary artery disease equivalent.
Azar RR; Badaoui G; Sarkis A; Azar M; Aydanian H; Harb S; Achkouty G; Kassab R
Am J Cardiol; 2010 Jul; 106(2):193-7. PubMed ID: 20599002
[TBL] [Abstract][Full Text] [Related]
33. Impact of short-term low-dose atorvastatin on low-density lipoprotein and high-density lipoprotein subfraction phenotype.
Xu RX; Guo YL; Li XL; Li S; Li JJ
Clin Exp Pharmacol Physiol; 2014 Jul; 41(7):475-81. PubMed ID: 24739131
[TBL] [Abstract][Full Text] [Related]
34. Increased oxidation resistance of atherogenic plasma lipoproteins at high vitamin E levels in non-vitamin E supplemented men.
Porkkala-Sarataho E; Nyyssönen K; Salonen JT
Atherosclerosis; 1996 Jul; 124(1):83-94. PubMed ID: 8800496
[TBL] [Abstract][Full Text] [Related]
35. Association between moderately oxidized low-density lipoprotein and high-density lipoprotein particle subclass distribution in hemodialyzed and post-renal transplant patients.
Kimak E; Hałabiś M; Baranowicz-Gąszczyk I; Solski J; Książek A
J Zhejiang Univ Sci B; 2011 May; 12(5):365-71. PubMed ID: 21528490
[TBL] [Abstract][Full Text] [Related]
36. The role of small, dense low density lipoprotein (LDL): a new look.
Packard C; Caslake M; Shepherd J
Int J Cardiol; 2000 Jun; 74 Suppl 1():S17-22. PubMed ID: 10856769
[TBL] [Abstract][Full Text] [Related]
37. Effect of atorvastatin therapy and conversion to tacrolimus on hypercholesterolemia and endothelial dysfunction after renal transplantation.
Wissing KM; Unger P; Ghisdal L; Broeders N; Berkenboom G; Carpentier Y; Abramowicz D
Transplantation; 2006 Sep; 82(6):771-8. PubMed ID: 17006324
[TBL] [Abstract][Full Text] [Related]
38. The effect of atorvastatin on serum lipids and lipoproteins in patients with homozyous familial hypercholesterolemia undergoing LDL-apheresis therapy.
Yamamoto A; Harada-Shiba M; Kawaguchi A; Oi K; Kubo H; Sakai S; Mikami Y; Imai T; Ito T; Kato H; Endo M; Sato I; Suzuki Y; Hori H
Atherosclerosis; 2000 Nov; 153(1):89-98. PubMed ID: 11058703
[TBL] [Abstract][Full Text] [Related]
39. Effect of niacin and atorvastatin on lipoprotein subclasses in patients with atherogenic dyslipidemia.
McKenney JM; McCormick LS; Schaefer EJ; Black DM; Watkins ML
Am J Cardiol; 2001 Aug; 88(3):270-4. PubMed ID: 11472706
[TBL] [Abstract][Full Text] [Related]
40. Oxidative structural modifications of low density lipoprotein in homozygous familial hypercholesterolemia.
Napoli C; Postiglione A; Triggiani M; Corso G; Palumbo G; Carbone V; Ruocco A; Ambrosio G; Montefusco S; Malorni A; Condorelli M; Chiariello M
Atherosclerosis; 1995 Dec; 118(2):259-73. PubMed ID: 8770320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
